Mitochondrial apoptosis and BH3 mimetics [version 1; referees: 3 approved]
The BCL2-selective BH3 mimetic venetoclax was recently approved for the treatment of relapsed, chromosome 17p-deleted chronic lymphocytic leukemia (CLL) and is undergoing extensive testing, alone and in combination, in lymphomas, acute leukemias, and solid tumors. Here we summarize recent advances i...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000 Research Ltd
2016-12-01
|
| Serie: | F1000Research |
| Soggetti: | |
| Accesso online: | https://f1000research.com/articles/5-2804/v1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|